Airway clearance in children with neuromuscular weakness

Current Opinion in Pediatrics

Volumn 18, Issue 3, 2006, Pages 277-281

  Panitch, Howard B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Airway clearance techniques; Cough; Neuromuscular disease

Indexed keywords

AERATION; ARTIFICIAL VENTILATION; BREATHING MUSCLE; CHEST WALL OSCILLATION; CHILD; COUGHING; DEVICE; HUMAN; LUNG CLEARANCE; MAXIMUM ALLOWABLE CONCENTRATION; MOBILIZATION; MUCUS SECRETION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; REVIEW; SAFETY; TRACHEOSTOMY;

AIRWAY OBSTRUCTION; CHILD; CHILD, PRESCHOOL; COUGH; HUMANS; INFANT; MUCUS; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASES; RESPIRATORY THERAPY;

EID: 33744815941     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000193297.40388.19     Document Type: Review

References (38)

1. Hardy KA, Anderson BD. Noninvasive clearance of airway secretions. Respir Care Clin N Am 1996; 2:323-345.
2. Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J 1999; 13:1177-1188.
3. Yates K, Festa M, Gillis J, et al. Outcome of children with neuromuscular disease admitted to paediatric intensive care. Arch Dis Child 2004; 89:170-175.
4. Eagle M, Baudouin SV, Chandler C, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002; 12:926-929.
5. Jeppesen J, Green A, Steffensen BF, Rahbek J. The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord 2003; 13:804-812.
6. Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004; 170:456-465.
7. Leith DE. Cough. In: Brain JD, Proctor D, Reid L, editors. Respiratory defense mechanisms, part II. New York: Marcel Dekker; 1977. pp. 545-592.
8. Ross BB, Gramiak R, Rahn H. Physical dynamics of the cough mechanism. J Appl Physiol 1955; 8:264-268.
9. Arora NS, Gal TJ. Cough dynamics during progressive expiratory muscle weakness in healthy curarized subjects. J Appl Physiol 1981; 51:494-498.
10. King M, Brock G, Lundell C. Clearance of mucus by simulated cough. J Appl Physiol 1985; 58:1776-1782.
11. Chaudri MB, Liu C, Hubbard R, et al. Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J 2002; 19:434-438.
12. Bach JR, Saporito LR. Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure. A different approach to weaning. Chest 1996; 110:1566-1571.
13. Kang SW, Bach JR. Maximum insufflation capacity. Chest 2000; 118:61-65.
14. Trebbia G, Lacombe M, Fermanian C, et al. Cough determinants in patients with neuromuscular disease. Respir Physiol Neurobiol 2005; 146:291-300. Although most of the patients in this large series of NMD patients were adults, information regarding individual components of the cough maneuver can be extrapolated to younger patients. The authors isolate techniques that enhance either the inspiratory or expiratory phase of cough (or both) to determine which are most effective, alone or in combination.
15. Sivasothy P, Brown L, Smith IE, Shneerson JM. Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax 2001; 56:438-444.
16. Castro C, Bach JR. Mechanical insufflation. Thorax 2002; 57:281.
17. Braun SR, Giovannoni R, O'Connor M. Improving the cough in patients with spinal cord injury. Am J Phys Med 1984; 63:1-10.
18. Kang SW, Kang YS, Moon JH, Yoo TW. Assisted cough and pulmonary compliance in patients with Duchenne muscular dystrophy. Yonsei Med J 2005; 46:233-238.
19. Bach JR. Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest 1993; 104:1553-1562.
20. Chatwin M, Ross E, Hart N, et al. Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J 2003; 21:502-508.
21. Barach AL, Beck GJ. Mechanical production of expiratory flow rates surpassing the capacity of human coughing. Am J Med Sci 1953; 226:241-249.
22. Barach AL, Beck GJ. Exsufflation with negative pressure; physiologic and clinical studies in poliomyelitis, bronchial asthma, pulmonary emphysema, and bronchiectasis. AMA Arch Intern Med 1954; 93:825-841.
23. Bach JR. Update and perspective on noninvasive respiratory muscle aids. Part 2: The expiratory aids. Chest 1994; 105:1538-1544.
24. Cherniack RM, Hildes JA, Alcock AJ. The clinical use of the exsufflator attachment for tank respirators in poliomyelitis. Ann Intern Med 1954; 40:540-548.
25. Miske LJ, Hickey EM, Kolb SM, et al. Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest 2004; 125:1406-1412.
26. Mier-Jedrzejowicz A, Brophy C, Green M. Respiratory muscle weakness during upper respiratory tract infections. Am Rev Respir Dis 1988; 138:5-7.
27. Poponick JM, Jacobs I, Supinski G, DiMarco AF. Effect of upper respiratory tract infection in patients with neuromuscular disease. Am J Respir Crit Care Med 1997; 156:659-664.
28. Tzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 2000; 118:1390-1396.
29. Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997; 112:1024-1028.
30. Airen M, McDonough J, Panitch HB. Cough peak flow measurements in normal school-age children. Am J Respir Crit Care Med 2004; 169:A896 [abstract].
31. Szeinberg A, Tabachnik E, Rashed N, et al. Cough capacity in patients with muscular dystrophy. Chest 1988; 94:1232-1235.
32. Gauld LM, Boynton A. Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy. Pediatr Pulmonol 2005; 39:457-460. This is one of only a few studies that examine the relationship of lung function to airway clearance in a population of children with NMD. The authors developed risk ratios for PCF < 270 l/min based on spirometric measurements.
33. Hansen LG, Warwick WJ, Hansen KL. Mucus transport mechanisms in relation to the effect of high frequency chest compression (HFCC) on mucus clearance. Pediatr Pulmonol 1994; 17:113-118.
34. Plioplys AV, Lewis S, Kasnicka I. Pulmonary vest therapy in pediatric long-term care. J Am Med Dir Assoc 2002; 3:318-321.
35. Birnkrant DJ, Pope JF, Lewarski J, et al. Persistent pulmonary consolidation treated with intrapulmonary percussive ventilation: a preliminary report. Pediatr Pulmonol 1996; 21:246-249.
36. Deakins K, Chatburn RL. A comparison of intrapulmonary percussive ventilation and conventional chest physiotherapy for the treatment of atelectasis in the pediatric patient. Respir Care 2002; 47:1162-1167.
37. Toussaint M, De Win H, Steens M, Soudon P. Effect of intrapulmonary percussive ventilation on mucus clearance in duchenne muscular dystrophy patients: a preliminary report. Respir Care 2003; 48:940-947.
38. Reardon CC, Christiansen D, Barnett ED, Cabral HJ. Intrapulmonary percussive ventilation vs incentive spirometry for children with neuromuscular disease. Arch Pediatr Adolesc Med 2005; 159:526-531. This study involved 18 children with NMD who lived in a residential facility. The authors were able to track not only days of hospitalization and of antibiotic use, but also number of days of school missed and number of extra respiratory treatments required in both groups, to determine which modality was more effective as part of a prevention program.